与环胺结局相关的遗传多态性以及狼性炎患者中毒性风险
Yen Yen Ari Indrawijaya1, Laniyati Hamijoyo, Aluicia Anita Artarini
1Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Batu, Indonesia. yenyen@uin-malang.ac.id.
Acta medica Indonesiana
|November 2, 2023
概括
环胺是第一线治疗狼性炎的药物. 在治疗前识别特定遗传标记 (SNP) 可以个性化治疗,并降低性炎患者的风险.
科学领域:
- 药物基因组学 药物基因组学
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
背景情况:
- 环胺是III,IV和V类狼性炎 (LN) 的标准诱导和维持疗法.
- 遗传变异,特别是单核酸多态性 (SNP),影响患者对环胺的反应和毒性.
- 没有先前的药物遗传研究在印尼狼性炎患者中进行过.
研究的目的:
- 突出需要在印尼狼肺炎患者中对特定SNP (rs4244285,rs4802101,rs7254579,rs3957356) 进行临床研究.
- 评估这些遗传标记物对个性化环胺治疗的潜力.
- 解决印尼狼肺炎患者群体中药物遗传学研究的差距.
主要方法:
- 审查关于环胺相关SNP和狼性炎的现有文献.
- 对各种印尼族群的SNP数据 (rs4244285) 的分析.
- 确定四个关键的SNP (rs4244285,rs4802101,rs7254579,rs3957356) 与环胺的疗效和毒性有关.
主要成果:
- 有四种特定的SNP与狼性炎中循环胺治疗结果有关.
- 针对多个印尼族群的rs4244285存在数据,这表明潜在的适用性.
- 目前,这些SNP对印尼狼性炎患者的影响的直接证据有限.
结论:
- 临床研究至关重要,以验证这些遗传标记在印尼狼肺炎患者中的有用性.
- 在循环胺治疗之前的药物遗传分析可以优化治疗策略.
- 需要个性化医疗方法来改善印尼狼性炎患者的治疗结果.
相关概念视频
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:20Chronopharmacokinetics: Time-Dependent Pharmacokinetics
145
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
145
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
204
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
204